oral PCSK9 | Drugs Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

28,432 results for “oral PCSK9”

PCSK9 inhibitor (oral, hypercholesterolemia/cardiovascular disease)

PCSK9 inhibitors (oral, cardiovascular diseases/hypercholesterolemia)

PCSK9

Conditions: coronary heart disease

Enlicitide Decanoate(Lipfendra)

Manufacturer: Merck & Co., Inc.

Conditions: Hypercholesterolemia, Heterozygous Familial Hypercholesterolemia

PBGENE-PCSK9

PCSK9 vaccine

PCSK9 targeting

PCSK9-EE

PCSK9 ligands

PCSK9-targeted PROTAC protein degrader program (oral, hypercholesterolemia)

Page 1 of 126